The Efficacy and Safety Trial of ENERGI-F703 in Diabetic Wound Healing: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial

被引：0
|
作者：
Young, Guang-Huar
Lin, Jiun-Tsai
Cheng, Yi-Fang
Chen, Han-Min
Huang, Chun-Fang
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-447-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
447-P
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of Useul for Dry Eye Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel, Phase 2 Clinical Trial
    Lyu, Yee-Ran
    Kwon, O-Jin
    Park, Bongkyun
    Jung, Hyun-A
    Lee, Ga-Young
    Kim, Chan-Sik
    HEALTHCARE, 2024, 12 (23)
  • [22] A Randomized, Placebo-controlled, Double-blind Clinical Trial of Bacteriophage Cocktails in Chronic Wound Infections
    Karn, Subhash Lal
    Bhartiya, Satyanam Kumar
    Pratap, Arvind
    Saroj, Sanjay Kumar
    Kumar, Rajesh
    Sahu, Minakshi
    Gangwar, Mayank
    Nath, Gopal
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2024,
  • [23] Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Zhang, Bo
    Cheng, Zhifeng
    Chen, Ji
    Zhang, Xin
    Liu, Dexue
    Jiang, Hongwei
    Ma, Guoqing
    Wang, Xiaoyun
    Gan, Shenglian
    Sun, Juan
    Jin, Ping
    Yi, Jianjun
    Shi, Bimin
    Ma, Jianhua
    Ye, Shandong
    Wang, Guixia
    Ji, Linong
    Gu, Xuejiang
    Yu, Ting
    An, Pei
    Deng, Huan
    Li, Haoyu
    Li, Li
    Ma, Qingyang
    Qian, Lei
    Yang, Wenying
    DIABETES CARE, 2024, 47 (01) : 160 - 168
  • [24] Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial
    Yiannakou, Yan
    Bouchoucha, Michel
    Schiefke, Ingolf
    Piessevaux, Hubert
    Filip, Rafal
    Stephenson, David
    Green, Alexandra
    Levine, Amy
    GASTROENTEROLOGY, 2014, 146 (05) : S160 - S160
  • [25] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [26] Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Karbalaee, Monire
    Jameie, Melika
    Amanollahi, Mobina
    TaghaviZanjani, Fateme
    Parsaei, Mohammadamin
    Basti, Fatemeh A.
    Mokhtari, Saba
    Moradi, Kamyar
    Akhondzadeh, Shahin
    SCHIZOPHRENIA RESEARCH, 2023, 254 : 92 - 98
  • [27] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [28] Efficacy and Safety of Vilazodone in Generalized Anxiety Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Thase, Michael E.
    Mathews, Maju
    Forero, Giovanna
    Nunez, Rene
    Chen, Changzheng
    Gommoll, Carl
    Durgam, Suresh
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S344 - S344
  • [29] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Ying Zhao
    Yuan-Yuan Yang
    Bao-Lin Yang
    Ya-Wei Du
    Da-Wei Ren
    Hong-Mei Zhou
    Jing Wang
    Hui-Min Yang
    Yao-Xian Wang
    Ying-Ying Zhang
    Sheng-Xian Wu
    Trials, 22
  • [30] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Zhao, Ying
    Yang, Yuan-Yuan
    Yang, Bao-Lin
    Du, Ya-Wei
    Ren, Da-Wei
    Zhou, Hong-Mei
    Wang, Jing
    Yang, Hui-Min
    Wang, Yao-Xian
    Zhang, Ying-Ying
    Wu, Sheng-Xian
    TRIALS, 2021, 22 (01)
12345